<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Encounter Summary</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Reason for Visit</a></li><li><a href="#id2">Encounter Details</a></li><li><a href="#id3">Social History</a></li><li><a href="#id4">Last Filed Vital Signs</a></li><li><a href="#id5">Patient Instructions</a></li><li><a href="#id6">Progress Notes</a></li><li><a href="#id7">Miscellaneous Notes</a></li><li><a href="#id8">Plan of Treatment</a></li><li><a href="#id9">Procedures</a></li><li><a href="#id10">Results</a></li><li><a href="#id11">Visit Diagnoses</a></li><li><a href="#id12">Additional Health Concerns</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Reason for Visit</a></h3><div><ul><li><table><colgroup><col width="25%"/><col width="75%"/></colgroup><thead><tr><th>Reason</th><th>Comments</th></tr></thead><tbody><tr ID="rfv2"><td ID="reasonrfv2">Follow-up</td><td/></tr><tr ID="rfv3"><td ID="reasonrfv3">Laboratory Results</td><td/></tr></tbody></table></li></ul></div><h3><a name="id2" href="#toc">Encounter Details</a></h3><div><table><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter4" class="xRowNormal"><td>[REDACTED] 10:00 AM PDT</td><td ID="encounter4type">Office Visit</td><td><p>UMC Centennial Primary Care</p><p>[REDACTED]</p><p>Suite 230</p><p>[REDACTED]-7108</p><p>[REDACTED]</p></td><td><p>[REDACTED], DO</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td><content>Type 2 diabetes mellitus with diabetic nephropathy, without long-term current use of insulin (CMS/HCC) (Primary Dx); <br/>Hypertensive left ventricular hypertrophy with heart failure (CMS/HCC); <br/>Hypertension associated with chronic kidney disease due to type 2 diabetes mellitus (CMS/HCC); <br/>Hypercoagulable state (CMS/HCC); <br/>Hyperlipidemia associated with type 2 diabetes mellitus (CMS/HCC); <br/>Type 2 diabetes mellitus with stage 3a chronic kidney disease, without long-term current use of insulin (CMS/HCC); <br/>Class 2 severe obesity due to excess calories with serious comorbidity and body mass index (BMI) of 35.0 to 35.9 in adult (CMS/HCC); <br/>Secondary hyperparathyroidism (CMS/HCC); <br/>Immunosuppressed status (CMS/HCC); <br/>Anemia in stage 3a chronic kidney disease (CMS/HCC); <br/>Hypothyroidism, unspecified type; <br/>Bronchospasm; <br/>Encounter for screening mammogram for breast cancer; <br/>Hyperuricemia; <br/>History of blood clots; <br/>Encounter for colorectal cancer screening; <br/>Depression screening negative; <br/>Former smoker; <br/>Immunization counseling; <br/>Patient had no falls in past year; <br/>Bradycardia; <br/>Age-related osteoporosis without current pathological fracture</content></td></tr></tbody></table></div><h3><a name="id3" href="#toc">Social History</a></h3><div><table ID="sochist29"><colgroup><col width="25%" span="2"/><col width="13%"/><col width="12%"/><col width="25%"/></colgroup><thead><tr><th>Tobacco Use</th><th>Types</th><th>Packs/Day</th><th>Years Used</th><th>Date</th></tr></thead><tbody><tr><td>Smoking Tobacco: Former</td><td>Cigarettes</td><td ID="sochist29packsperday">0.5</td><td>20</td><td>1975 - [REDACTED]</td></tr><tr ID="sochist29smokeless" class="xRowAlt"><td>Smokeless Tobacco: Never</td><td/><td/><td/><td/></tr></tbody></table><table><tbody><tr><td ID="sochist29cessation" class="xnoIndent"><span class="xcellHeader">Tobacco Cessation:</span> Counseling Given: Yes<br/><span class="xcellHeader">Comments:</span> PLEASE DO NOT CONSIDER ANY SMOKING DEVICES <br/></td></tr></tbody></table><table><colgroup><col width="25%" span="2"/><col width="50%"/></colgroup><thead><tr><th>Alcohol Use</th><th>Standard Drinks/Week</th><th>Comments</th></tr></thead><tbody><tr><td ID="alcoholStatus">No</td><td>0 (1 standard drink = 0.6 oz pure alcohol)</td><td/></tr></tbody></table><table ID="sdohassess1"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Humiliation, Afraid, Rape, and Kick questionnaire</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess1pair1"><td ID="sdohassess1pair1ques">Within the last year, have you been afraid of your partner or ex-partner?</td><td ID="sdohassess1pair1ans">Patient declined</td><td>[REDACTED]</td></tr><tr ID="sdohassess1pair2"><td ID="sdohassess1pair2ques">Within the last year, have you been humiliated or emotionally abused in other ways by your partner or ex-partner?</td><td ID="sdohassess1pair2ans">Patient declined</td><td>[REDACTED]</td></tr><tr ID="sdohassess1pair3"><td ID="sdohassess1pair3ques">Within the last year, have you been kicked, hit, slapped, or otherwise physically hurt by your partner or ex-partner?</td><td ID="sdohassess1pair3ans">Patient declined</td><td>[REDACTED]</td></tr><tr ID="sdohassess1pair4"><td ID="sdohassess1pair4ques">Within the last year, have you been raped or forced to have any kind of sexual activity by your partner or ex-partner?</td><td ID="sdohassess1pair4ans">Patient declined</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess2"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Social Connection and Isolation Panel [NHANES]</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess2pair1"><td ID="sdohassess2pair1ques">In a typical week, how many times do you talk on the phone with family, friends, or neighbors?</td><td ID="sdohassess2pair1ans">Patient declined</td><td>[REDACTED]</td></tr><tr ID="sdohassess2pair2"><td ID="sdohassess2pair2ques">How often do you get together with friends or relatives?</td><td ID="sdohassess2pair2ans">Patient declined</td><td>[REDACTED]</td></tr><tr ID="sdohassess2pair3"><td ID="sdohassess2pair3ques">How often do you attend church or religious services?</td><td ID="sdohassess2pair3ans">Patient declined</td><td>[REDACTED]</td></tr><tr ID="sdohassess2pair4"><td ID="sdohassess2pair4ques">Do you belong to any clubs or organizations such as church groups, unions, fraternal or athletic groups, or school groups?</td><td ID="sdohassess2pair4ans">Patient declined</td><td>[REDACTED]</td></tr><tr ID="sdohassess2pair5"><td ID="sdohassess2pair5ques">How often do you attend meetings of the clubs or organizations you belong to?</td><td ID="sdohassess2pair5ans">Patient declined</td><td>[REDACTED]</td></tr><tr ID="sdohassess2pair6"><td ID="sdohassess2pair6ques">Are you married, widowed, divorced, separated, never married, or living with a partner?</td><td ID="sdohassess2pair6ans">Patient declined</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess3"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>AUDIT-C</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess3pair1"><td ID="sdohassess3pair1ques">Q1: How often do you have a drink containing alcohol?</td><td ID="sdohassess3pair1ans">Never</td><td>[REDACTED]</td></tr><tr ID="sdohassess3pair2"><td ID="sdohassess3pair2ques">Q2: How many drinks containing alcohol do you have on a typical day when you are drinking?</td><td ID="sdohassess3pair2ans">Patient does not drink</td><td>[REDACTED]</td></tr><tr ID="sdohassess3pair3"><td ID="sdohassess3pair3ques">Q3: How often do you have six or more drinks on one occasion?</td><td ID="sdohassess3pair3ans">Never</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess5"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Overall Financial Resource Strain (CARDIA)</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess5pair1"><td ID="sdohassess5pair1ques">How hard is it for you to pay for the very basics like food, housing, medical care, and heating?</td><td ID="sdohassess5pair1ans">Patient declined</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess7"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>PHQ-2</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess7pair1"><td ID="sdohassess7pair1ques">PHQ-9 Total Score</td><td ID="sdohassess7pair1ans">0</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess8"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Finnish Institute of Occupational Health - Occupational Stress Questionnaire</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess8pair1"><td ID="sdohassess8pair1ques">Do you feel stress - tense, restless, nervous, or anxious, or unable to sleep at night because your mind is troubled all the time - these days?</td><td ID="sdohassess8pair1ans">Patient declined</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess9"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Exercise Vital Sign</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess9pair1"><td ID="sdohassess9pair1ques">On average, how many days per week do you engage in moderate to strenuous exercise (like a brisk walk)?</td><td ID="sdohassess9pair1ans">0 days</td><td>[REDACTED]</td></tr><tr ID="sdohassess9pair2"><td ID="sdohassess9pair2ques">On average, how many minutes do you engage in exercise at this level?</td><td ID="sdohassess9pair2ans">Patient declined</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess10"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Hunger Vital Sign</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess10pair1"><td ID="sdohassess10pair1ques">Within the past 12 months, you worried that your food would run out before you got the money to buy more.</td><td ID="sdohassess10pair1ans">Patient declined</td><td>[REDACTED]</td></tr><tr ID="sdohassess10pair2"><td ID="sdohassess10pair2ques">Within the past 12 months, the food you bought just didn't last and you didn't have money to get more.</td><td ID="sdohassess10pair2ans">Patient declined</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess11"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>PRAPARE - Transportation</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess11pair1"><td ID="sdohassess11pair1ques">In the past 12 months, has lack of transportation kept you from medical appointments or from getting medications?</td><td ID="sdohassess11pair1ans">Patient declined</td><td>[REDACTED]</td></tr><tr ID="sdohassess11pair2"><td ID="sdohassess11pair2ques">In the past 12 months, has lack of transportation kept you from meetings, work, or from getting things needed for daily living?</td><td ID="sdohassess11pair2ans">Patient declined</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess12"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Housing Stability Vital Sign</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess12pair1"><td ID="sdohassess12pair1ques">In the last 12 months, was there a time when you were not able to pay the mortgage or rent on time?</td><td ID="sdohassess12pair1ans">Patient refused</td><td>[REDACTED]</td></tr><tr ID="sdohassess12pair2"><td ID="sdohassess12pair2ques">Number of Places Lived in the Last Year</td><td ID="sdohassess12pair2ans">Not on file</td><td>[REDACTED]</td></tr><tr ID="sdohassess12pair3"><td ID="sdohassess12pair3ques">In the last 12 months, was there a time when you did not have a steady place to sleep or slept in a shelter (including now)?</td><td ID="sdohassess12pair3ans">Patient refused</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess6"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>PHQ-9</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess6pair1"><td ID="sdohassess6pair1ques">PHQ-9 Total Score</td><td ID="sdohassess6pair1ans">0</td><td>[REDACTED]</td></tr></tbody></table><table><colgroup><col width="25%"/><col width="75%"/></colgroup><thead><tr><th>Pregnant</th><th>Comments</th></tr></thead><tbody><tr><td>No</td><td/></tr></tbody></table><table><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Sex and Gender Information</th><th>Value</th><th>Date Recorded</th></tr></thead><tbody><tr ID="BirthSex33"><td>Sex Assigned at Birth</td><td ID="BirthSex33Value">Female</td><td>[REDACTED]  1:29 PM PDT</td></tr><tr ID="LegalSex34"><td>Legal Sex</td><td ID="LegalSex34Value">Female</td><td>[REDACTED]  1:23 AM PDT</td></tr><tr ID="GenderIdentity30"><td>Gender Identity</td><td ID="GenderIdentity30Value">Female</td><td>[REDACTED]  1:29 PM PDT</td></tr><tr ID="SexualOrientation31"><td>Sexual Orientation</td><td ID="SexualOrientation31Value">Straight</td><td>[REDACTED]  1:29 PM PDT</td></tr></tbody></table><table><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>COVID-19 Exposure</th><th>Response</th><th>Date Recorded</th></tr></thead><tbody><tr ID="COVID-19Exp32"><td>In the last 10 days, have you been in contact with someone who was confirmed or suspected to have Coronavirus/COVID-19?</td><td ID="COVID-19Exp32Value">No / Unsure</td><td>[REDACTED]  9:55 AM PDT</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id4" href="#toc">Last Filed Vital Signs</a></h3><div><table><colgroup><col width="25%" span="4"/></colgroup><thead><tr><th>Vital Sign</th><th>Reading</th><th>Time Taken</th><th>Comments</th></tr></thead><tbody><tr class="xRowNormal"><td class="xcellHeader">Blood Pressure</td><td><span class="content_span">114</span>/<span class="content_span">66</span></td><td>[REDACTED]  9:55 AM PDT</td><td/></tr><tr ID="pulse_5760608100" class="xRowAlt"><td class="xcellHeader">Pulse</td><td>67</td><td>[REDACTED]  9:55 AM PDT</td><td/></tr><tr ID="temp_5760608100" class="xRowNormal"><td class="xcellHeader">Temperature</td><td>36.3 °C (97.4 °F)</td><td>[REDACTED]  9:55 AM PDT</td><td/></tr><tr ID="resp_5760608100" class="xRowAlt"><td class="xcellHeader">Respiratory Rate</td><td>17</td><td>[REDACTED]  9:55 AM PDT</td><td/></tr><tr ID="SpO2_5760608100" class="xRowNormal"><td class="xcellHeader">Oxygen Saturation</td><td>98%</td><td>[REDACTED]  9:55 AM PDT</td><td/></tr><tr ID="inhaled_" class="xRowAlt"><td class="xcellHeader">Inhaled Oxygen Concentration</td><td>-</td><td>-</td><td/></tr><tr ID="weight_5760608100" class="xRowNormal"><td class="xcellHeader">Weight</td><td>102 kg (224 lb)</td><td>[REDACTED]  9:55 AM PDT</td><td/></tr><tr ID="height_5760608100" class="xRowAlt"><td class="xcellHeader">Height</td><td>166.4 cm (5' 5.5")</td><td>[REDACTED]  9:55 AM PDT</td><td/></tr><tr ID="bmi_5760608100" class="xRowNormal"><td class="xcellHeader">Body Mass Index</td><td>36.71</td><td>[REDACTED]  9:55 AM PDT</td><td/></tr></tbody></table>documented in this encounter</div><h3><a name="id5" href="#toc">Patient Instructions</a></h3><div><ul><li>Patient Instructions: <ul><li><p> <span class="xLabel">[REDACTED], DO - [REDACTED] 10:00 AM PDT</span></p><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>Follow-up in Return in about 6 months (around [REDACTED]), or if symptoms worsen or fail to improve, for Recheck, Next scheduled follow-up, COMPREHENSIVE WELLNESS. <br/>Labs to be done 2 weeks before appointment. <br/>THE LAB REQUEST HAS BEEN SENT TO YOUR LAB.<br/>Please bring ALL medication bottles with you,  IF NEW PRESCRIPTIONS WERE GIVEN OR REFILLS WERE REQUESTED THE NEW PRESCRIPTIONS HAVE BEEN SENT TO YOUR PHARMACY AS PER YOUR REQUEST.   PLEASE BRING any NEW reports from other doctors or ANY hospital visit NOTES. Patient are advised to contact ON LINE CARE 24/7 CONNECTION @ www.umconlinecare.com TO SPEAK TO A PHYSICIAN if problems/symptoms arise or go to a UMC QUICK CARE/ER IF SYMPTOMS WORSEN.  PLEASE SIGN UP FOR "MY CHART".  YOU MAY RECEIVE REFERRAL NOTIFICATIONS THROUGH THIS SITE.  YOU CAN ALSO SEND ME MESSAGES, VIEW YOUR LAB RESULTS, ASK FOR REFILLS, SCHEDULE APPOINTMENTS, AND ASK FOR UPDATED REFERRALS TO SPECIALIST, AND MORE THROUGH THIS PATIENT PORTAL. IF YOU HAVE TESTS ORDERED YOU CAN VIEW THE RESULTS, WHEN YOU COMPLETE THEM, THROUGH YOUR MY CHART APPLICATION. </content><br/><span class="xLabel">Electronically signed by [REDACTED], DO at [REDACTED] 10:59 AM PDT</span><br/><br/></li></ul></li></ul>documented in this encounter</div><h3><a name="id6" href="#toc">Progress Notes</a></h3><div><ul><li>[REDACTED], DO - [REDACTED] 10:00 AM PDT: <content><content><span class="xLabel">Formatting of this note is different from the original.</span><br/>Patient ID: [REDACTED] is a  [REDACTED]. female <br/>DOB:  [REDACTED]<br/><br/>Assessment &amp; Plan  <br/>Problem List  <br/><br/> <br/> Circulatory <br/> Hypertension associated with chronic kidney disease due to type 2 diabetes mellitus (CMS/HCC) <br/> Overview <br/>  SEEING NEPHROLOGY<br/>olmesartan<br/>chlorthalidone<br/> <br/> <br/> Current Assessment &amp; Plan <br/>  Hypertension is unchanged.<br/>Continue current treatment regimen.<br/>Blood pressure will be reassessed at the next regular appointment.<br/> <br/> <br/> Relevant Medications <br/> ferrous gluconate ([REDACTED]) 324 mg (38 mg iron) tablet <br/> chlorthalidone (HYGROTEN) 25 mg tablet <br/> pravastatin (PRAVACHOL) 80 mg tablet <br/> SITagliptin phosphate (JANUVIA) 100 mg tablet <br/> Other Relevant Orders <br/> Comprehensive metabolic panel <br/> Hypertensive left ventricular hypertrophy with heart failure (CMS/HCC) <br/> Overview <br/>  BENICAR/CHLORTHALIDONE<br/> <br/> <br/> Current Assessment &amp; Plan <br/>  HEART FAILURE STABLE CONTINUE MEDS<br/> <br/> <br/> Relevant Medications <br/> chlorthalidone (HYGROTEN) 25 mg tablet <br/> pravastatin (PRAVACHOL) 80 mg tablet <br/> Other Relevant Orders <br/> Comprehensive metabolic panel <br/> Bradycardia <br/> <br/> Digestive <br/> Class 2 severe obesity due to excess calories with serious comorbidity and body mass index (BMI) of 35.0 to 35.9 in adult (CMS/HCC) <br/> Current Assessment &amp; Plan <br/>  Obesity is unchanged.<br/>Discussed the patient's BMI.  The BMI is above average; BMI management plan is completed.<br/>diet<br/> <br/> <br/> <br/> Genitourinary <br/> Type 2 diabetes mellitus with stage 3 chronic kidney disease (CMS/HCC) <br/> Overview <br/>  NEPHROLOGY<br/> <br/> <br/> Current Assessment &amp; Plan <br/>  renal is unchanged. <br/>Continue current treatment regimen.<br/>Diabetes will be reassessed [REDACTED].<br/> <br/> <br/> Relevant Medications <br/> ferrous gluconate ([REDACTED]) 324 mg (38 mg iron) tablet <br/> chlorthalidone (HYGROTEN) 25 mg tablet <br/> pravastatin (PRAVACHOL) 80 mg tablet <br/> SITagliptin phosphate (JANUVIA) 100 mg tablet <br/> Other Relevant Orders <br/> Hemoglobin A1C <br/> Comprehensive metabolic panel <br/> Anemia in stage 3a chronic kidney disease (CMS/HCC) <br/> Current Assessment &amp; Plan <br/>  ANEMIA  is unchanged.<br/>Continue current treatment regimen.<br/>Renal condition will be reassessed [REDACTED].<br/> <br/> <br/> Relevant Medications <br/> ferrous gluconate ([REDACTED]) 324 mg (38 mg iron) tablet <br/> chlorthalidone (HYGROTEN) 25 mg tablet <br/> pravastatin (PRAVACHOL) 80 mg tablet <br/> Other Relevant Orders <br/> CBC with auto differential <br/> Ferritin <br/> Iron <br/> <br/> Musculoskeletal <br/> Age-related osteoporosis without current pathological fracture <br/> Overview <br/>  DEXA 2021  HIP FRACTURE 2019<br/> <br/> <br/> Relevant Medications <br/> alendronate (FOSAMAX) 70 mg tablet <br/> <br/> Endocrine/Metabolic <br/> Hyperlipidemia associated with type 2 diabetes mellitus (CMS/HCC) <br/> Overview <br/>  pravastatin<br/> <br/> <br/> Current Assessment &amp; Plan <br/>  Lipid abnormalities are LDL AT GOAL.<br/>Nutritional counseling was provided. and Pharmacotherapy as ordered.<br/>Lipids will be reassessed [REDACTED].<br/> <br/> <br/> Relevant Medications <br/> pravastatin (PRAVACHOL) 80 mg tablet <br/> SITagliptin phosphate (JANUVIA) 100 mg tablet <br/> Secondary hyperparathyroidism (CMS/HCC) <br/> Overview <br/>  ZEMPLAR SEEING NEPHROLOGY<br/> <br/> <br/> Current Assessment &amp; Plan <br/>  LAB WNL CONTINUE MED<br/> <br/> <br/> Relevant Orders <br/> Comprehensive metabolic panel <br/> Vitamin D 25 hydroxy <br/> Type 2 diabetes mellitus, without long-term current use of insulin (CMS/HCC) - Primary <br/> Overview <br/>  Acarbose 25<br/>JAnuvia 100<br/> <br/> <br/> Current Assessment &amp; Plan <br/>  Diabetes is unchanged. <br/>Continue current treatment regimen.<br/>Diabetes will be reassessed [REDACTED].<br/> <br/> <br/> Relevant Medications <br/> pravastatin (PRAVACHOL) 80 mg tablet <br/> SITagliptin phosphate (JANUVIA) 100 mg tablet <br/> Other Relevant Orders <br/> Hemoglobin A1C <br/> Comprehensive metabolic panel <br/> Vitamin D 25 hydroxy <br/> Hemoglobin A1C <br/> Comprehensive metabolic panel <br/> Hypothyroid <br/> Overview <br/>  LEVOTHYROXINE 125 MCG<br/> <br/> <br/> Current Assessment &amp; Plan <br/>  LAB WNL CONTINUE DOSE<br/> <br/> <br/> Relevant Medications <br/> levothyroxine (SYNTHROID) 125 mcg tablet <br/> Hyperuricemia <br/> Overview <br/>  NEPHROLOGY<br/> <br/> <br/> Current Assessment &amp; Plan <br/>  LAB WNL CONTINUE PLAN<br/> <br/> <br/> <br/> Hematologic <br/> Hypercoagulable state (CMS/HCC) <br/> Overview <br/>  H/O BLOOD CLOTS<br/> <br/> <br/> Current Assessment &amp; Plan <br/>  STABLE CONTINUE PLAN ON LOW DOSE ASA<br/> <br/> <br/> Relevant Orders <br/> CBC with auto differential <br/> <br/> Immune <br/> Immunosuppressed status (CMS/HCC) <br/> Overview <br/>  DM/CKD/OBESE<br/> <br/> <br/> Current Assessment &amp; Plan <br/>  STABLE CONTINUE PLAN<br/> <br/> <br/> Relevant Orders <br/> CBC with auto differential <br/> <br/> Other <br/> Encounter for screening mammogram for breast cancer <br/> Overview <br/>  S/P MASTECTOMY LEFT MAMMO 2022 NEG<br/> <br/> <br/> Current Assessment &amp; Plan <br/>  SCHEDULED FOR SEPTEMBER<br/> <br/> <br/> History of blood clots <br/> Overview <br/>  OCCURRED AFTER SURGERY OFF ELIQUIS SEEN BY HEMATOLOGY AND THEY STOPPED ELIQUIS. 2020<br/> <br/> <br/> Relevant Medications <br/> pravastatin (PRAVACHOL) 80 mg tablet <br/> Encounter for colorectal cancer screening <br/> Overview <br/>  LAST COLONOSCOPY 5/2021 POLYPS NEXT 2025<br/> <br/> <br/> Current Assessment &amp; Plan <br/>  UP TO DATE NEXT 2025<br/> <br/> <br/> Depression screening negative <br/> Overview <br/>  DENIES DEPRESSION DECLINES TREATMENT/REFERRAL<br/> <br/> <br/> Former smoker <br/> Overview <br/>  Quit 1995<br/> <br/> <br/> Immunization counseling <br/> Overview <br/>  WEBIZ 2021 FLU SHOT 2020 PNEUMONIA 2020 SHINGLE SHOT NO<br/> <br/> <br/> Patient had no falls in past year <br/> Overview <br/>  NO FALLS 2020<br/> <br/> <br/><br/>Patient instructed that if any concerns or adverse effects should arise to contact us. Return to clinic or urgent care if symptoms persist and do not resolve or if any other symptoms arise. Proceed to ER if symptoms worse. Patient verbalized understanding and agrees to current assessment and treatment plan. All questions answered. <br/><br/>Subjective <br/>Chief Complaint:<br/>Chief Complaint <br/>Patient presents with <br/> Follow-up <br/> Laboratory Results <br/><br/>HPI<br/> Patient is here for routine check up and follow up on multiple medical issues. Patient is compliant to  diet and medications. Denies any medication side effect , nor any new complaint . <br/><br/>Past Medical History: <br/>Diagnosis Date <br/> Cataract [REDACTED] <br/> OPTHO <br/> Closed right hip fracture (CMS/HCC) [REDACTED] <br/> S/P SURGERY <br/> History of left breast cancer  <br/> Hypothyroid  <br/><br/>Past Surgical History: <br/>Procedure Laterality Date <br/> BACK SURGERY   <br/> COLON SURGERY  1989 <br/> colectomy, SBO <br/> COLONOSCOPY W/ POLYPECTOMY  2016 <br/> denies family hx of crc <br/> COLONOSCOPY W/ POLYPECTOMY  [REDACTED] <br/> c/o aurora. With polyps. denies family hx of crc. Due in [REDACTED] <br/> FEMUR FRACTURE SURGERY   <br/> MASTECTOMY Left 1996 <br/> cancer <br/> NECK SURGERY   <br/> THYROIDECTOMY, PARTIAL   <br/><br/>Social History <br/><br/>Tobacco Use <br/> Smoking status: Former <br/>  Packs/day: 0.50 <br/>  Years: 20.00 <br/>  Additional pack years: 0.00 <br/>  Total pack years: 10.00 <br/>  Types: Cigarettes <br/>  Start date: 1975 <br/>  Quit date: [REDACTED] <br/>  Years since quitting: 28.5 <br/> Smokeless tobacco: Never <br/> Tobacco comments: <br/>  PLEASE DO NOT CONSIDER ANY SMOKING DEVICES  <br/>Vaping Use <br/> Vaping Use: Never used <br/>Substance Use Topics <br/> Alcohol use: No <br/> Drug use: No <br/><br/> Medications:<br/>Current Outpatient Medications <br/>Medication Sig Dispense Refill <br/> acarbose (PRECOSE) 25 mg tablet TAKE ONE TABLET BY MOUTH THREE TIMES DAILY WITH MEALS 270 tablet 0 <br/> albuterol (PROAIR, PROVENTIL, VENTOLIN) HFA inhaler 90 mcg/puff 2 puffs every 4 hours for wheeze,cough 1 each 3 <br/> ascorbic acid, vitamin C, 500 mg tablet Take 500 mg by mouth daily.     <br/> aspirin 81 mg EC tablet Take 81 mg by mouth daily.   <br/> cholecalciferol, vitamin D3, (VITAMIN D3 ORAL) Take 4,000 Units 2 (two) times a day by mouth  Two 2000 unit tablets daily.   <br/> cyanocobalamin (VITAMIN B12) 1,000 mcg tablet Take 100 mcg by mouth daily. 2 tablets daily    <br/> ferrous gluconate ([REDACTED]) 324 mg (38 mg iron) tablet Take 324 mg by mouth   <br/> FREESTYLE LITE STRIPS strip TEST BLOOD SUGAR TWICE DAILY. 200 strip 3 <br/> lancets 33 gauge misc 1 Units 2 (two) times a day. 200 each 3 <br/> olmesartan (BENICAR) 5 mg tablet TAKE TWO TABLETS BY MOUTH DAILY 200 tablet 3 <br/> paricalcitoL (ZEMPLAR) 1 mcg capsule 1 On Mondays and 1 On Fridays.    <br/> zinc 50 mg tablet Take 50 mg by mouth   <br/> alendronate (FOSAMAX) 70 mg tablet Take 1 tablet by mouth every 7 days in am w/glass of water on empty stomach. Dont take anything else or lie down for 30 mins. 12 tablet 3 <br/> chlorthalidone (HYGROTEN) 25 mg tablet Take 1 tablet (25 mg total) in the morning by mouth. 100 tablet 1 <br/> levothyroxine (SYNTHROID) 125 mcg tablet TAKE ONE TABLET BY MOUTH ONE TIME DAILY 100 tablet 2 <br/> montelukast (SINGULAIR) 10 mg tablet Take 1 tablet (10 mg total) nightly by mouth  Take one daily for wheezing or asthma. 100 tablet 3 <br/> pravastatin (PRAVACHOL) 80 mg tablet TAKE ONE TABLET BY MOUTH ONE TIME DAILY 100 tablet 3 <br/> SITagliptin phosphate (JANUVIA) 100 mg tablet TAKE ONE TABLET BY MOUTH ONE TIME DAILY 100 tablet 1 <br/><br/>No current facility-administered medications for this visit. <br/><br/>Medications Discontinued During This Encounter <br/>Medication Reason <br/> chlorthalidone (HYGROTEN) 25 mg tablet Reorder <br/> montelukast (SINGULAIR) 10 mg tablet Reorder <br/> alendronate (FOSAMAX) 70 mg tablet Reorder <br/> SITagliptin phosphate (JANUVIA) 100 mg tablet Reorder <br/> pravastatin (PRAVACHOL) 80 mg tablet Reorder <br/> levothyroxine (SYNTHROID) 125 mcg tablet Reorder <br/><br/>ALLERGIES:<br/>Adhesive tape-silicones and Latex<br/>Review of Systems <br/>All other systems reviewed and are negative.<br/><br/>Objective  <br/>Vitals: <br/> [REDACTED] 0955 <br/>BP: 114/66 <br/>BP Location: Right arm <br/>Patient Position: Sitting <br/>Pulse: 67 <br/>Resp: 17 <br/>Temp: 36.3 °C (97.4 °F) <br/>TempSrc: Temporal <br/>SpO2: 98% <br/>Weight: 102 kg (224 lb) <br/>Height: 166.4 cm (5' 5.5") <br/><br/>Body mass index is 36.71 kg/m².<br/>Physical Exam<br/>Vitals and nursing note reviewed. <br/>Constitutional:  <br/>   Appearance: She is obese. <br/>Pulmonary: <br/>   Effort: Pulmonary effort is normal. No respiratory distress. <br/>Musculoskeletal: <br/>   Right lower leg: Edema present. <br/>   Left lower leg: Edema present. <br/>Neurological: <br/>   Mental Status: She is alert. Mental status is at [REDACTED]. <br/>   Sensory: No sensory deficit. <br/>Psychiatric:    <br/>   Mood and Affect: Mood normal. <br/><br/></content><br/><span class="xLabel">Electronically signed by [REDACTED], DO at [REDACTED] 10:59 AM PDT</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id7" href="#toc">Miscellaneous Notes</a></h3><div><ul><li>Assessment &amp; Plan Note - [REDACTED], DO - [REDACTED] 10:50 AM PDT: <content><span class="Bold">Associated Problem(s): Encounter for colorectal cancer screening</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>UP TO DATE NEXT 2025</content><br/><span class="xLabel">Electronically signed by [REDACTED], DO at [REDACTED] 10:50 AM PDT</span><br/></content></li><li>Assessment &amp; Plan Note - [REDACTED], DO - [REDACTED] 10:50 AM PDT: <content><span class="Bold">Associated Problem(s): Hypercoagulable state (CMS/HCC)</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>STABLE CONTINUE PLAN ON LOW DOSE ASA</content><br/><span class="xLabel">Electronically signed by [REDACTED], DO at [REDACTED] 10:50 AM PDT</span><br/></content></li><li>Assessment &amp; Plan Note - [REDACTED], DO - [REDACTED] 10:49 AM PDT: <content><span class="Bold">Associated Problem(s): Hyperuricemia</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>LAB WNL CONTINUE PLAN</content><br/><span class="xLabel">Electronically signed by [REDACTED], DO at [REDACTED] 10:49 AM PDT</span><br/></content></li><li>Assessment &amp; Plan Note - [REDACTED], DO - [REDACTED] 10:48 AM PDT: <content><span class="Bold">Associated Problem(s): Hypothyroid</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>LAB WNL CONTINUE DOSE</content><br/><span class="xLabel">Electronically signed by [REDACTED], DO at [REDACTED] 10:49 AM PDT</span><br/></content></li><li>Assessment &amp; Plan Note - [REDACTED], DO - [REDACTED] 10:48 AM PDT: <content><span class="Bold">Associated Problem(s): Encounter for screening mammogram for breast cancer</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>SCHEDULED FOR SEPTEMBER</content><br/><span class="xLabel">Electronically signed by [REDACTED], DO at [REDACTED] 10:48 AM PDT</span><br/></content></li><li>Assessment &amp; Plan Note - [REDACTED], DO - [REDACTED] 10:47 AM PDT: <content><span class="Bold">Associated Problem(s): Anemia in stage 3a chronic kidney disease (CMS/HCC)</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>ANEMIA  is unchanged.<br/>Continue current treatment regimen.<br/>Renal condition will be reassessed [REDACTED].</content><br/><span class="xLabel">Electronically signed by [REDACTED], DO at [REDACTED] 10:48 AM PDT</span><br/></content></li><li>Assessment &amp; Plan Note - [REDACTED], DO - [REDACTED] 10:47 AM PDT: <content><span class="Bold">Associated Problem(s): Immunosuppressed status (CMS/HCC)</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>STABLE CONTINUE PLAN</content><br/><span class="xLabel">Electronically signed by [REDACTED], DO at [REDACTED] 10:47 AM PDT</span><br/></content></li><li>Assessment &amp; Plan Note - [REDACTED], DO - [REDACTED] 10:46 AM PDT: <content><span class="Bold">Associated Problem(s): Type 2 diabetes mellitus, without long-term current use of insulin (CMS/HCC)</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>Diabetes is unchanged. <br/>Continue current treatment regimen.<br/>Diabetes will be reassessed [REDACTED].</content><br/><span class="xLabel">Electronically signed by [REDACTED], DO at [REDACTED] 10:46 AM PDT</span><br/></content></li><li>Assessment &amp; Plan Note - [REDACTED], DO - [REDACTED] 10:46 AM PDT: <content><span class="Bold">Associated Problem(s): Hypertensive left ventricular hypertrophy with heart failure (CMS/HCC)</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>HEART FAILURE STABLE CONTINUE MEDS</content><br/><span class="xLabel">Electronically signed by [REDACTED], DO at [REDACTED] 10:46 AM PDT</span><br/></content></li><li>Assessment &amp; Plan Note - [REDACTED], DO - [REDACTED] 10:45 AM PDT: <content><span class="Bold">Associated Problem(s): Secondary hyperparathyroidism (CMS/HCC)</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>LAB WNL CONTINUE MED</content><br/><span class="xLabel">Electronically signed by [REDACTED], DO at [REDACTED] 10:45 AM PDT</span><br/></content></li><li>Assessment &amp; Plan Note - [REDACTED], DO - [REDACTED] 10:45 AM PDT: <content><span class="Bold">Associated Problem(s): Hyperlipidemia associated with type 2 diabetes mellitus (CMS/HCC)</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>Lipid abnormalities are LDL AT GOAL.<br/>Nutritional counseling was provided. and Pharmacotherapy as ordered.<br/>Lipids will be reassessed [REDACTED].</content><br/><span class="xLabel">Electronically signed by [REDACTED], DO at [REDACTED] 10:45 AM PDT</span><br/></content></li><li>Assessment &amp; Plan Note - [REDACTED], DO - [REDACTED] 10:45 AM PDT: <content><span class="Bold">Associated Problem(s): Class 2 severe obesity due to excess calories with serious comorbidity and body mass index (BMI) of 35.0 to 35.9 in adult (CMS/HCC)</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>Obesity is unchanged.<br/>Discussed the patient's BMI.  The BMI is above average; BMI management plan is completed.<br/>diet</content><br/><span class="xLabel">Electronically signed by [REDACTED], DO at [REDACTED] 10:45 AM PDT</span><br/></content></li><li>Assessment &amp; Plan Note - [REDACTED], DO - [REDACTED] 10:44 AM PDT: <content><span class="Bold">Associated Problem(s): Hypertension associated with chronic kidney disease due to type 2 diabetes mellitus (CMS/HCC)</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>Hypertension is unchanged.<br/>Continue current treatment regimen.<br/>Blood pressure will be reassessed at the next regular appointment.</content><br/><span class="xLabel">Electronically signed by [REDACTED], DO at [REDACTED] 10:45 AM PDT</span><br/></content></li><li>Assessment &amp; Plan Note - [REDACTED], DO - [REDACTED] 10:44 AM PDT: <content><span class="Bold">Associated Problem(s): Type 2 diabetes mellitus with stage 3 chronic kidney disease (CMS/HCC)</span><br/><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>renal is unchanged. <br/>Continue current treatment regimen.<br/>Diabetes will be reassessed [REDACTED].</content><br/><span class="xLabel">Electronically signed by [REDACTED], DO at [REDACTED] 10:44 AM PDT</span><br/></content></li><li>Result Encounter Note - [REDACTED], MD - [REDACTED] 10:00 AM PDT: <content><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/>Patient has follow up</content><br/><span class="xLabel">Electronically signed by [REDACTED], MD at [REDACTED]  1:57 PM PST</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id8" href="#toc">Plan of Treatment</a></h3><div><p>Not on file</p>documented as of this encounter</div><h3><a name="id9" href="#toc">Procedures</a></h3><div><table><colgroup><col width="25%"/><col width="10%"/><col width="15%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Procedure Name</th><th>Priority</th><th>Date/Time</th><th>Associated Diagnosis</th><th>Comments</th></tr></thead><tbody><tr ID="procedure78" class="xRowNormal"><td><span class="content_span">GLYCOHEMOGLOBIN</span></td><td>Routine</td><td>[REDACTED]  9:13 AM PST</td><td><p>Type 2 diabetes mellitus with diabetic nephropathy, without long-term current use of insulin (CMS/HCC)</p><p>Type 2 diabetes mellitus with stage 3a chronic kidney disease, without long-term current use of insulin (CMS/HCC)</p></td><td><p>Results for this procedure are in the <span class="xLink2-Result.1.2.840.114350.1.13.495.2.7.2.798268.90592353">results section</span>.</p></td></tr><tr ID="procedure77" class="xRowAlt"><td><span class="content_span">VITAMIN D 25 HYDROXY</span></td><td>Routine</td><td>[REDACTED]  9:13 AM PST</td><td><p>Type 2 diabetes mellitus with diabetic nephropathy, without long-term current use of insulin (CMS/HCC)</p><p>Secondary hyperparathyroidism (CMS/HCC)</p></td><td><p>Results for this procedure are in the <span class="xLink2-Result.1.2.840.114350.1.13.495.2.7.2.798268.90592355">results section</span>.</p></td></tr><tr ID="procedure76" class="xRowNormal"><td><span class="content_span">CBC WITH AUTO DIFF</span></td><td>Routine</td><td>[REDACTED]  9:13 AM PST</td><td><p>Immunosuppressed status (CMS/HCC)</p><p>Anemia in stage 3a chronic kidney disease (CMS/HCC)</p><p>Hypercoagulable state (CMS/HCC)</p></td><td><p>Results for this procedure are in the <span class="xLink2-Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356">results section</span>.</p></td></tr><tr ID="procedure75" class="xRowAlt"><td><span class="content_span">IRON</span></td><td>Routine</td><td>[REDACTED]  9:13 AM PST</td><td><p>Anemia in stage 3a chronic kidney disease (CMS/HCC)</p></td><td><p>Results for this procedure are in the <span class="xLink2-Result.1.2.840.114350.1.13.495.2.7.2.798268.90592358">results section</span>.</p></td></tr><tr ID="procedure74" class="xRowNormal"><td><span class="content_span">FERRITIN</span></td><td>Routine</td><td>[REDACTED]  9:13 AM PST</td><td><p>Anemia in stage 3a chronic kidney disease (CMS/HCC)</p></td><td><p>Results for this procedure are in the <span class="xLink2-Result.1.2.840.114350.1.13.495.2.7.2.798268.90592357">results section</span>.</p></td></tr><tr ID="procedure73" class="xRowAlt"><td><span class="content_span">COMPREHENSIVE METABOLIC PANEL</span></td><td>Routine</td><td>[REDACTED]  9:13 AM PST</td><td><p>Hypertensive left ventricular hypertrophy with heart failure (CMS/HCC)</p><p>Hypertension associated with chronic kidney disease due to type 2 diabetes mellitus (CMS/HCC)</p><p>Type 2 diabetes mellitus with diabetic nephropathy, without long-term current use of insulin (CMS/HCC)</p><p>Type 2 diabetes mellitus with stage 3a chronic kidney disease, without long-term current use of insulin (CMS/HCC)</p><p>Secondary hyperparathyroidism (CMS/HCC)</p></td><td><p>Results for this procedure are in the <span class="xLink2-Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354">results section</span>.</p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id10" href="#toc">Results</a></h3><div><ul><li>Iron ([REDACTED]  9:13 AM PST): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col width="10%" span="2"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592358.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592358.Comp1Name">IRON, SERUM</td><td>75</td><td>37 - 145 UG/DL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592358.Comp1Signature"/></tr></tbody></table><table><colgroup><col width="20%" span="5"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592358.Specimen">Blood</td><td>Peripheral blood / Unknown</td><td/><td>[REDACTED]  9:13 AM PST</td><td>[REDACTED]  9:35 AM PST</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p>CPL - [REDACTED]  4:29 AM PST</p><p><span class="content_span">PT FASTING</span><br/><span class="content_span"> </span><br/><span class="content_span">Testing Performed At:</span><br/><span class="content_span">CPL:  Clinical Pathology Laboratories, [REDACTED]</span><br/><span class="content_span">Laboratory Director: [REDACTED], M.D., CLIA #: 45D0505003</span></p></td></tr></tbody></table><table><colgroup><col width="20%" span="2"/><col width="60%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th><th>Result Status</th></tr></thead><tbody><tr><td>[REDACTED] DO</td><td>LAB BLOOD ORDERABLES</td><td>Final Result</td></tr></tbody></table><table><colgroup><col width="20%" span="3"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592358.PerformingLab"><p>CPL</p></td><td><p>[REDACTED][REDACTED]</p></td><td><p>[REDACTED], NV 89109</p></td><td><p/></td></tr></tbody></table></li><li>Ferritin ([REDACTED]  9:13 AM PST): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col width="10%" span="2"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592357.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592357.Comp1Name">FERRITIN</td><td>176</td><td>13 - 200 NG/ML</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592357.Comp1Signature"/></tr></tbody></table><table><colgroup><col width="20%" span="5"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592357.Specimen">Blood</td><td>Peripheral blood / Unknown</td><td/><td>[REDACTED]  9:13 AM PST</td><td>[REDACTED]  9:35 AM PST</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p>CPL - [REDACTED]  4:50 AM PST</p><p><span class="content_span">PT FASTING</span><br/><span class="content_span"> </span><br/><span class="content_span">Testing Performed At:</span><br/><span class="content_span">CPL:  Clinical Pathology Laboratories, [REDACTED]</span><br/><span class="content_span">Laboratory Director: [REDACTED], M.D., CLIA #: 45D0505003</span></p></td></tr></tbody></table><table><colgroup><col width="20%" span="2"/><col width="60%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th><th>Result Status</th></tr></thead><tbody><tr><td>[REDACTED] DO</td><td>LAB BLOOD ORDERABLES</td><td>Final Result</td></tr></tbody></table><table><colgroup><col width="20%" span="3"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592357.PerformingLab"><p>CPL</p></td><td><p>[REDACTED][REDACTED]</p></td><td><p>[REDACTED]</p></td><td><p/></td></tr></tbody></table></li><li>(ABNORMAL) CBC with auto differential ([REDACTED]  9:13 AM PST): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col width="10%" span="2"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp1Name">WBC</td><td>6.7</td><td>3.5 - 11.0 K/UL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp1Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp2" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp2Name">RBC</td><td><span class="xflagData">3.78</span><span class="xflagData"> (L)</span></td><td>3.80 - 5.40 M/UL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp2Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp3" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp3Name">HEMOGLOBIN</td><td>11.8</td><td>11.5 - 15.5 G/DL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp3Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp4" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp4Name">Hematocrit</td><td>34.6</td><td>34.0 - 45.0 %</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp4Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp5" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp5Name">MCV</td><td>91.5</td><td>80.0 - 99.0 fL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp5Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp6" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp6Name">MCH</td><td>31.2</td><td>25.0 - 33.0 PG</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp6Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp7" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp7Name">MCHC</td><td>34.1</td><td>31.0 - 36.0 G/DL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp7Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp8" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp8Name">RDW</td><td>12.8</td><td>%</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp8Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp9" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp9Name">NEUTROPHILS</td><td>50.1</td><td>%</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp9Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp10" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp10Name">LYMPHOCYTES</td><td>39.0</td><td>%</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp10Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp11" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp11Name">MONOCYTES</td><td>8.0</td><td>%</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp11Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp12" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp12Name">EOSINOPHILS</td><td>2.2</td><td>%</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp12Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp13" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp13Name">BASOPHILS</td><td>0.6</td><td>%</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp13Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp14" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp14Name">IMMATURE GRANULOCYTES </td><td>0.1</td><td>%</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp14Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp15" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp15Name">NUCLEATED RBC</td><td>0.0</td><td>0.0  /100 WBC'S</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp15Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp16" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp16Name">PLATELET COUNT</td><td>260</td><td>130 - 400 K/UL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp16Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp17" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp17Name">ABSOLUTE NEUTROPHILS</td><td>3.37</td><td>1.50 - 7.50 K/UL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp17Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp18" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp18Name">ABSOLUTE LYMPHOCYTES</td><td>2.63</td><td>1.00 - 4.00 K/UL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp18Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp19" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp19Name">ABSOLUTE MONOCYTES</td><td>0.54</td><td>0.20 - 1.00 K/UL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp19Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp20" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp20Name">ABSOLUTE EOSINOPHILS</td><td>0.15</td><td>0.00 - 0.50 K/UL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp20Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp21" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp21Name">ABSOLUTE BASOPHILS</td><td>0.04</td><td>0.00 - 0.20 K/UL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp21Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp22" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp22Name">ABS IMMATURE GRANULOCYTES </td><td>0.01</td><td>0.00 - 0.10 K/UL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp22Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp23" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp23Name">ABS NUCLEATED RBCS </td><td>0.00</td><td>K/UL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Comp23Signature"/></tr></tbody></table><table><colgroup><col width="20%" span="5"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.Specimen">Blood</td><td>Peripheral blood / Unknown</td><td/><td>[REDACTED]  9:13 AM PST</td><td>[REDACTED]  9:35 AM PST</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p>CPL - [REDACTED]  4:32 AM PST</p><p><span class="content_span">PT FASTING</span><br/><span class="content_span"> </span><br/><span class="content_span">Testing Performed At:</span><br/><span class="content_span">CPL:  Clinical Pathology Laboratories, [REDACTED]</span><br/><span class="content_span">Laboratory Director: [REDACTED], M.D., CLIA #: 45D0505003</span></p></td></tr></tbody></table><table><colgroup><col width="20%" span="2"/><col width="60%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th><th>Result Status</th></tr></thead><tbody><tr><td>[REDACTED] DO</td><td>LAB BLOOD ORDERABLES</td><td>Final Result</td></tr></tbody></table><table><colgroup><col width="20%" span="3"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592356.PerformingLab"><p>CPL</p></td><td><p>[REDACTED][REDACTED]</p></td><td><p>[REDACTED]</p></td><td><p/></td></tr></tbody></table></li><li>Vitamin D 25 hydroxy ([REDACTED]  9:13 AM PST): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col width="10%" span="2"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592355.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592355.Comp1Name">VITAMIN D, 25 OH</td><td><span class="content_span">33</span></td><td>SEE BELOW NG/ML</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592355.Comp1Signature"/></tr><tr class="xRowNormal xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><br/><content class="xpre"> <br/>     ***EFFECTIVE [REDACTED], PLEASE NOTE NEW METHODOLOGY IS***<br/>                  ELECTROCHEMILUMINESCENCE BINDING ASSAY.<br/> <br/>NOTE: 25-HYDROXYVITAMIN D ASSAY INCLUDES 25-HYDROXYVITAMIN D2<br/>      AND D3.  <br/> <br/>                ***** INTERPRETIVE RANGES *****<br/>PEDIATRIC (&lt;17 YEARS) . . . . . . . . . . . NG/ML         20-100<br/>ADULT:<br/>  INSUFFICIENT  . . . . . . . . . . . . . . NG/ML         &lt;20<br/>  SUBOPTIMAL  . . . . . . . . . . . . . . . NG/ML         20-29<br/>  OPTIMAL . . . . . . . . . . . . . . . . . NG/ML         30-100<br/> <br/> <br/></content></content></td></tr></tbody></table><table><colgroup><col width="20%" span="5"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592355.Specimen">Blood</td><td>Peripheral blood / Unknown</td><td/><td>[REDACTED]  9:13 AM PST</td><td>[REDACTED]  9:35 AM PST</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p>CPL - [REDACTED]  4:51 AM PST</p><p><span class="content_span">PT FASTING</span><br/><span class="content_span"> </span><br/><span class="content_span">Testing Performed At:</span><br/><span class="content_span">CPL:  Clinical Pathology Laboratories, [REDACTED]</span><br/><span class="content_span">Laboratory Director: [REDACTED], M.D., CLIA #: 45D0505003</span></p></td></tr></tbody></table><table><colgroup><col width="20%" span="2"/><col width="60%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th><th>Result Status</th></tr></thead><tbody><tr><td>[REDACTED] DO</td><td>LAB BLOOD ORDERABLES</td><td>Final Result</td></tr></tbody></table><table><colgroup><col width="20%" span="3"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592355.PerformingLab"><p>CPL</p></td><td><p>[REDACTED][REDACTED]</p></td><td><p>[REDACTED], NV 89109</p></td><td><p/></td></tr></tbody></table></li><li>(ABNORMAL) Comprehensive metabolic panel ([REDACTED]  9:13 AM PST): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col width="10%" span="2"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp1Name">GLUCOSE</td><td><span class="xflagData">100</span><span class="xflagData"> (H)</span></td><td>70 - 99 MG/DL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp1Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp2" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp2Name">BUN</td><td>22</td><td>8 - 23 MG/DL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp2Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp3" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp3Name">CREATININE</td><td>1.07</td><td>0.60 - 1.30 MG/DL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp3Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp4" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp4Name">EGFR NON-AFRICAN AMER.</td><td><span class="xflagData">55</span><span class="xflagData"> (L)</span></td><td>&gt;60 ML/MIN/1.73</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp4Signature"/></tr><tr class="xRowAlt xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><br/><content class="xpre"> <br/>The NKF-ASN Taskforce recommends use of Cystatin C to confirm eGFR in<br/>adults at risk for CKD.  CPL offers eGFR with Cystatin C-Creatinine<br/>using the 2021 CKD-EPI eGFR_creat-cystat equation (order code 3057) to<br/>increase the accuracy of estimated GFR. For more information, contact<br/>your account executive or see announcement at<br/>https://www.cpllabs.com/egfr-cr-cys<br/> <br/> <br/></content></content></td></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp5" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp5Name">CALCULATED BUN/CREAT</td><td>21</td><td>6 - 28 RATIO</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp5Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp6" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp6Name">SODIUM</td><td>139</td><td>133 - 146 MEQ/L</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp6Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp7" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp7Name">POTASSIUM</td><td>3.5</td><td>3.5 - 5.4 MEQ/L</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp7Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp8" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp8Name">CHLORIDE</td><td>99</td><td>95 - 107 MEQ/L</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp8Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp9" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp9Name">CARBON DIOXIDE</td><td>24</td><td>19 - 31 MEQ/L</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp9Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp10" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp10Name">CALCIUM</td><td>9.5</td><td>8.5 - 10.5 MG/DL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp10Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp11" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp11Name">PROTEIN, TOTAL</td><td>7.5</td><td>6.1 - 8.3 G/DL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp11Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp12" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp12Name">ALBUMIN</td><td>4.6</td><td>3.5 - 5.2 G/DL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp12Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp13" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp13Name">CALCULATED GLOBULIN</td><td>2.9</td><td>1.9 - 3.7 G/DL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp13Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp14" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp14Name">CALCULATED A/G RATIO</td><td>1.6</td><td>1.0 - 2.6 RATIO</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp14Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp15" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp15Name">BILIRUBIN, TOTAL</td><td>0.2</td><td>&lt;=1.2 MG/DL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp15Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp16" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp16Name">ALKALINE PHOSPHATASE</td><td>47</td><td>40 - 142 U/L</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp16Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp17" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp17Name">SGOT (AST)</td><td>24</td><td>9 - 40 U/L</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp17Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp18" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp18Name">SGPT (ALT)</td><td>25</td><td>5 - 40 U/L</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Comp18Signature"/></tr></tbody></table><table><colgroup><col width="20%" span="5"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.Specimen">Blood</td><td>Peripheral blood / Unknown</td><td/><td>[REDACTED]  9:13 AM PST</td><td>[REDACTED]  9:35 AM PST</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p>CPL - [REDACTED]  4:29 AM PST</p><p><span class="content_span">PT FASTING</span><br/><span class="content_span"> </span><br/><span class="content_span">Testing Performed At:</span><br/><span class="content_span">CPL:  Clinical Pathology Laboratories, [REDACTED]</span><br/><span class="content_span">Laboratory Director: [REDACTED], M.D., CLIA #: 45D0505003</span></p></td></tr></tbody></table><table><colgroup><col width="20%" span="2"/><col width="60%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th><th>Result Status</th></tr></thead><tbody><tr><td>[REDACTED] DO</td><td>LAB BLOOD ORDERABLES</td><td>Final Result</td></tr></tbody></table><table><colgroup><col width="20%" span="3"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592354.PerformingLab"><p>CPL</p></td><td><p>[REDACTED][REDACTED]</p></td><td><p>[REDACTED]</p></td><td><p/></td></tr></tbody></table></li><li>(ABNORMAL) Hemoglobin A1C ([REDACTED]  9:13 AM PST): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col width="10%" span="2"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592353.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592353.Comp1Name">HEMOGLOBIN A1c </td><td><span class="xflagData">6.5</span><span class="xflagData"> (H)</span></td><td>4.2 - 5.6 %</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592353.Comp1Signature"/></tr><tr class="xRowNormal xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><br/><content class="xpre"> <br/>         AMERICAN DIABETES ASSOCIATION GUIDELINES FOR HGB A1C:<br/>          PREDIABETES/INCREASED RISK . . . . . . . 5.7-6.4%<br/>          DIAGNOSIS OF DIABETES  . . . . . . . . . &gt;=6.5%<br/>            WITH CONFIRMATION OR APPROPRIATE SYMPTOMS<br/> <br/>     NOTE: ASSAY MAY BE AFFECTED BY HEMOGLOBINOPATHIES (SICKLE<br/>     CELL ANEMIA, S-C DISEASE, OTHERS) OR ARTIFICIALLY LOWERED BY<br/>     DECREASED RED CELL SURVIVAL (HEMOLYTIC ANEMIAS, BLOOD LOSS,<br/>     ETC.).  CONSIDER ALTERNATE TESTING OR LABORATORY CONSULTATION.<br/> <br/> <br/></content></content></td></tr><tr ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592353.Comp2" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592353.Comp2Name">ESTIMATED AVERAGE GLUCOSE </td><td><span class="xflagData">140</span><span class="xflagData"> (H)</span></td><td>&lt;117 MG/DL</td><td/><td/><td>CPL</td><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592353.Comp2Signature"/></tr></tbody></table><table><colgroup><col width="20%" span="5"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592353.Specimen">Blood</td><td>Peripheral blood / Unknown</td><td/><td>[REDACTED]  9:13 AM PST</td><td>[REDACTED]  9:35 AM PST</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p>CPL - [REDACTED]  4:53 AM PST</p><p><span class="content_span">PT FASTING</span><br/><span class="content_span"> </span><br/><span class="content_span">Testing Performed At:</span><br/><span class="content_span">CPL:  Clinical Pathology Laboratories, [REDACTED]</span><br/><span class="content_span">Laboratory Director: [REDACTED], M.D., CLIA #: 45D0505003</span></p></td></tr></tbody></table><table><colgroup><col width="20%" span="2"/><col width="60%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th><th>Result Status</th></tr></thead><tbody><tr><td>[REDACTED] DO</td><td>LAB BLOOD ORDERABLES</td><td>Final Result</td></tr></tbody></table><table><colgroup><col width="20%" span="3"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.495.2.7.2.798268.90592353.PerformingLab"><p>CPL</p></td><td><p>[REDACTED][REDACTED]</p></td><td><p>[REDACTED]</p></td><td><p/></td></tr></tbody></table></li></ul>documented in this encounter</div><h3><a name="id11" href="#toc">Visit Diagnoses</a></h3><div><table><colgroup><col width="100%"/></colgroup><thead><tr><th>Diagnosis</th></tr></thead><tbody><tr ID="vdx5" class="xRowNormal"><td><p><span class="content_span">Type 2 diabetes mellitus with diabetic nephropathy, without long-term current use of insulin (CMS/HCC)</span><span class="content_span"> - Primary</span></p></td></tr><tr ID="vdx6" class="xRowAlt"><td><p><span class="content_span">Hypertensive left ventricular hypertrophy with heart failure (CMS/HCC)</span></p></td></tr><tr ID="vdx7" class="xRowNormal"><td><p><span class="content_span">Hypertension associated with chronic kidney disease due to type 2 diabetes mellitus (CMS/HCC)</span></p></td></tr><tr ID="vdx8" class="xRowAlt"><td><p><span class="content_span">Hypercoagulable state (CMS/HCC)</span></p><p>Primary hypercoagulable state</p></td></tr><tr ID="vdx9" class="xRowNormal"><td><p><span class="content_span">Hyperlipidemia associated with type 2 diabetes mellitus (CMS/HCC)</span></p></td></tr><tr ID="vdx10" class="xRowAlt"><td><p><span class="content_span">Type 2 diabetes mellitus with stage 3a chronic kidney disease, without long-term current use of insulin (CMS/HCC)</span></p></td></tr><tr ID="vdx11" class="xRowNormal"><td><p><span class="content_span">Class 2 severe obesity due to excess calories with serious comorbidity and body mass index (BMI) of 35.0 to 35.9 in adult (CMS/HCC)</span></p></td></tr><tr ID="vdx12" class="xRowAlt"><td><p><span class="content_span">Secondary hyperparathyroidism (CMS/HCC)</span></p><p>Secondary hyperparathyroidism (of renal origin)</p></td></tr><tr ID="vdx13" class="xRowNormal"><td><p><span class="content_span">Immunosuppressed status (CMS/HCC)</span></p></td></tr><tr ID="vdx14" class="xRowAlt"><td><p><span class="content_span">Anemia in stage 3a chronic kidney disease (CMS/HCC)</span></p></td></tr><tr ID="vdx15" class="xRowNormal"><td><p><span class="content_span">Hypothyroidism, unspecified type</span></p></td></tr><tr ID="vdx16" class="xRowAlt"><td><p><span class="content_span">Bronchospasm</span></p><p>Acute bronchospasm</p></td></tr><tr ID="vdx17" class="xRowNormal"><td><p><span class="content_span">Encounter for screening mammogram for breast cancer</span></p></td></tr><tr ID="vdx18" class="xRowAlt"><td><p><span class="content_span">Hyperuricemia</span></p><p>Other abnormal blood chemistry</p></td></tr><tr ID="vdx19" class="xRowNormal"><td><p><span class="content_span">History of blood clots</span></p></td></tr><tr ID="vdx20" class="xRowAlt"><td><p><span class="content_span">Encounter for colorectal cancer screening</span></p></td></tr><tr ID="vdx21" class="xRowNormal"><td><p><span class="content_span">Depression screening negative</span></p></td></tr><tr ID="vdx22" class="xRowAlt"><td><p><span class="content_span">Former smoker</span></p><p>Personal history of tobacco use, presenting hazards to health</p></td></tr><tr ID="vdx23" class="xRowNormal"><td><p><span class="content_span">Immunization counseling</span></p></td></tr><tr ID="vdx24" class="xRowAlt"><td><p><span class="content_span">Patient had no falls in past year</span></p></td></tr><tr ID="vdx25" class="xRowNormal"><td><p><span class="content_span">Bradycardia</span></p><p>Other specified cardiac dysrhythmias</p></td></tr><tr ID="vdx26" class="xRowAlt"><td><p><span class="content_span">Age-related osteoporosis without current pathological fracture</span></p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id12" href="#toc">Additional Health Concerns</a></h3><div><table><colgroup><col width="50%" span="2"/></colgroup><thead><tr><th>Assessment</th><th>Noted Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="assessment1">PHQ-9 Depression Total Score: 0</td><td>[REDACTED]  9:59 AM PDT</td></tr><tr class="xRowAlt"><td ID="assessment2">A fall risk assessment has been completed for the patient</td><td>[REDACTED] 11:25 AM PST</td></tr><tr class="xRowNormal"><td ID="assessment3">PHQ-2 Depression Total Score: 0</td><td>[REDACTED]  9:59 AM PDT</td></tr></tbody></table>documented as of this encounter</div><br/><br/>
</body></html>